News Release

COVID-19 vaccination and parent-reported symptomatic child asthma prevalence

JAMA Network Open

Peer-Reviewed Publication

JAMA Network

About The Study: Researchers found that higher COVID-19 vaccination rates may confer protection against symptomatic asthma in children. COVID-19 vaccination yields prophylactic benefits against SARS-CoV-2 infection for individual children and may also protect against other human coronaviruses through cross-reactive antibody responses.

Corresponding Author: To contact the corresponding author, Matthew M. Davis, M.D., M.A.P.P., email

To access the embargoed study: Visit our For The Media website at this link


Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication. 

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.